JACC
HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
 QUICK SEARCH:   [advanced]


     


J Am Coll Cardiol, 1995; 25:915-921
© 1995 by the American College of Cardiology Foundation
This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pedretti, R.
Right arrow Articles by Caru, B
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pedretti, R.
Right arrow Articles by Caru, B

Effects of oral pirenzepine on heart rate variability and baroreceptor reflex sensitivity after acute myocardial infarction

RF Pedretti, E Colombo, SS Braga, L Ballardini, and B Caru

Division of Cardiology, Clinica del Lavoro Foundation, Istituto Ricovero e Cura a Carattere Scientifico (IRCCS), Tradate, Italy.

OBJECTIVES. Our aims were 1) to assess whether oral pirenzepine could increase indexes of cardiac vagal activity in postinfarction patients, and 2) to compare the effects of this agent with those of transdermal scopolamine. BACKGROUND. Depression of vagal tone and reflexes predicts a poor arrhythmic outcome after myocardial infarction. Interventions for shifting the sympathovagal balance toward vagal dominance are now of increased clinical interest. Intravenous pirenzepine increases RR interval variability in normal volunteers, a finding that could have therapeutic implications if confirmed in postinfarction patients after oral administration of the drug. METHODS. In a single-blind placebo-controlled crossover trial, short-term RR interval variability and baroreceptor reflex sensitivity were evaluated in 20 patients an average of 19 +/- 6 days after infarction. Analysis was performed during control conditions and during administration of placebo, oral pirenzepine and transdermal scopolamine. RESULTS. Compared with placebo, at a dose of 25 mg twice daily, pirenzepine significantly increased all time and frequency domain measures of RR interval variability and augmented baroreceptor reflex sensitivity by 60% (mean +/- 1 SD 10.4 +/- 5.9 vs. 6.5 +/- 3.2 ms/mm Hg, p = 0.0007). Pirenzepine and scopolamine showed a similar vagomimetic effect, but the overall incidence of adverse effects was lower with pirenzepine (1 [5%] of 20 vs. 10 [50%] of 20). CONCLUSIONS. In patients with a recent myocardial infarction, oral pirenzepine proved equal to transdermal scopolamine in significantly increasing indexes of cardiac vagal activity. These data suggest that oral pirenzepine may have a therapeutic potential for preventing malignant ventricular arrhythmias after infarction.


This article has been cited by other articles:


Home page
J Am Coll CardiolHome page
D. Roach, W. Wilson, D. Ritchie, and R. Sheldon
Dissection of long-range heart rate variability: Controlled induction of prognostic measures by activity in the laboratory
J. Am. Coll. Cardiol., June 16, 2004; 43(12): 2271 - 2277.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
D. Le Guludec, A. Cohen-Solal, J. Delforge, N. Delahaye, A. Syrota, and P. Merlet
Increased Myocardial Muscarinic Receptor Density in Idiopathic Dilated Cardiomyopathy : An In Vivo PET Study
Circulation, November 18, 1997; 96(10): 3416 - 3422.
[Abstract] [Full Text]




HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
Copyright © 1995 by the American College of Cardiology Foundation.